1Ruff-Jamison S, Zhong Z, Wen Z, et al. Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver. J Biol Chem 1994; 269:21933-5.
2Yu CL, Meyer D J, Campbell GS, et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995; 269:81-3.
3Su Wc, Kitagawa M, Xue N, et al. Activation of Stat 1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia typeⅡ dwarfism. Nature 1997; 386:288-92.
4Chin YE, Kitagawa M, Su WC, et al. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF 1/C1P 1 mediated by STAT1. Science 1996; 272:719-22.
5Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997; 17:5328-37.
6Kortylewski M, Kujawski M, Wang T, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 2005; 11:1314-21.
7Blumberg RS, Strober W. Prospects for research in inflammatory bowel disease. JAMA 2001; 285:643-7.
8Plevy SE, Landers C J, Prehn J, et al. A role for TNF-alpha and mueosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997; 159:6276-82.
9Kosiewicz M M, Nast CC, Krishnan A, et al. Th 1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J Clin Invest 2001; 107:695-702.
10Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992; 9:383-391.
